-+ 0.00%
-+ 0.00%
-+ 0.00%

VIKING THERAPEUTICS ANNOUNCES INITIATION OF VK2735 ORAL PHASE 3 CLINICAL PROGRAM IN PATIENTS WITH OBESITY

路透·10/14/2026 11:05:00

請登錄查看新聞詳情